?:abstract
|
-
Corona virus disease or its pandemic (COVID-19), because of novel corona virus-2 (SARS-nCoV-2), has become a big challenge worldwide to discover an e®ective therapeutic regime for its prevention and treatment Researchers and scientists are continuously exploring new ideas and strategies to come up with an e®ective treatment that can confront against the novel corona virus, but no signi¯cant results have been documented in any of the reported study up till Neither an e®ective vaccine nor any antiviral therapeutic agent has been approved to treat Covid-19 In the present scenario, immunotherapy by transferring of antibody enriched convalescent sera to the infected patient seems to be one of the promising treatment approaches This paper focuses on exploring the suitability of using CP transfusion therapy on Covid-19 patients, highlighting the risks and challenges associated with its treatment for gaining maximum clinical bene¯ts and better treatment outcome The ¯ndings derived from the serological assays provide a valuable information that would help to support diagnosis, treatment and prevention of SARS-CoV-2 infection
|